Search - tctmd.com

Displaying 101 - 120 of 422

Sort: Relevancy | Date

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Todd Neale

March 25, 2024

News Daily News

Internists in HF: A Solution to a Lack of Care?

Yael L. Maxwell

March 19, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Presentation THT 2024

A Novel Cardiac Scale and Algorithm for Detecting Worsening Congestion Preceding Heart Failure Events (HFEs): A Preliminary Analysis of the SCALE-HF 1 Study

Presenter: Marat Fudim

March 06, 2024

Presentation THT 2024

Novel Strategies in mRNA Therapeutics for Heart Failure

Presenter: John Cooke

March 05, 2024

Presentation THT 2024

Use of a Novel Intra-Aortic Entrainment Pump for a Patient With Restrictive Cardiomyopathy and Recurrent Cardiorenal Syndrome

Presenter: Davis Kimaiyo

March 05, 2024

Presentation THT 2024

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

Presenter: Elena M. Donald

March 04, 2024

Presentation THT 2024

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

Presenter: Ahmad Masri

March 04, 2024

Presentation THT Abstracts 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

Presentation THT 2024

BiVacor: A Novel, Magnetically Levitated Rotary Pump-Based TAH

Presenter: Daniel Timms

March 04, 2024

Presentation THT 2024

CoreWave: A Novel Pump Concept

Presenter: Palak Shah

March 04, 2024

Advertisement

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

TCTMD’s Top 10 Most Popular Stories for March 2024

April 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Internists in HF: A Solution to a Lack of Care?

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Semaglutide Winning Streak Continues in CKD With FLOW

A Novel Cardiac Scale and Algorithm for Detecting Worsening Congestion Preceding Heart Failure Events (HFEs): A Preliminary Analysis of the SCALE-HF 1 Study

Novel Strategies in mRNA Therapeutics for Heart Failure

Use of a Novel Intra-Aortic Entrainment Pump for a Patient With Restrictive Cardiomyopathy and Recurrent Cardiorenal Syndrome

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

BiVacor: A Novel, Magnetically Levitated Rotary Pump-Based TAH

CoreWave: A Novel Pump Concept

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content